跳至主要内容
临床试验/IRCT20211029052907N3
IRCT20211029052907N3尚未招募3 期

Effectiveness and safety of Metformin gel in prevention of acute radiation dermatitis in breast cancer patients (a randomized, double-blind, placebo-controlled clinical trial)

Zanjan University of Medical Sciences0 个研究点目标入组 52 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
52

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
Female

入选标准

  • female patients
  • age = 18 years
  • with a histologically confirmed diagnosis of localized invasive breast carcinoma
  • receiving adjuvant radiotherapy at least 50 Gy after breast surgery (breast-conserving surgery or mastectomy)

排除标准

  • Prior history of radiotherapy to the treatment fields
  • Inflammatory or metastatic breast carcinoma
  • Concurrent chemotherapy with RT (except trastuzumab and hormonal therapy)
  • Generalized skin disorder
  • Connective tissue disorders
  • Untreated surgical wounds
  • Known allergy or hypersensitivity history to metformin or any other ingredients of the gel

研究者

相似试验